Skip to main content

Table 4 Analysis of the correlation between the upregulation of lymph node metastasis-related molecular markers and lymph node metastasis in colorectal cancer (CRC) tissues

From: Over-expression of Nav1.6 channels is associated with lymph node metastases in colorectal cancer

Gene

Lymph node metastasis CRC

Non-Lymph node metastasis CRC

T

P

hCCR2

4.21 ± 3.67

2.24 ± 2.12

2.949

0.005

hTGFbetaR

0.94 ± 0.54

0.91 ± 0.55

0.215

0.830

hCD3e

2.65 ± 1.52

2.52 ± 2.12

0.304

0.762

hCCR4

3.40 ± 3.50

2.03 ± 1.85

2.168

0.035

hP53

2.23 ± 1.5 2

2.33 ± 1.59

− 0.305

0.761

hCCR7

6.21 ± 5.56

6.44 ± 6.65

− 0.172

0.864

hBcl2

2.41 ± 1.45

2.14 ± 1.50

0.883

0.380

h1L2Ra

6.45 ± 5.13

4.68 ± 3.65

1.973

0.051

hCD8a

11.55 ± 8.95

11.21 ± 12.49

0.144

0.886

  1. Two-tailed t test in SPSS20.0 was used to determine whether lymph node metastasis was a group variable, and the expression of each immune factor was a test variable. When the sig value of the Levene test is greater than 0.05, the T value and the P value are obtained by assuming the variance is equal. When the sig value of the Levene test is less than 0.05, the T value and the P value are obtained by assuming that the variances are not equal. P < 0.05 is marked in italic